Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia

Trial Profile

Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs DA 9701 (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Sponsors Dong-A ST
  • Most Recent Events

    • 15 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 24 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top